STAT+: Teladoc stock slides despite business growth, Medtronic CEO talks innovation

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. 

Teladoc’s stock slides despite business growth

Teladoc Health on Tuesday reported solid third quarter earnings showing $660 million in revenue for 8% year-over-year growth and improvement across business lines including BetterHelp and its closely watched chronic care segment.

Continue to STAT+ to read the full story…